Course Date

February 22, 2025.

Course Description

This ISCD Orthopedic Osteoporosis and Densitometry Course is a live activity consisting of a variety of sessions in didactic lectures, question and answer sessions and case-based interactive presentations. Overall, this variety of learning formats will allow learners to receive information from leading experts in important topic areas. Further, the structure and format of the course will provide learners with opportunities to engage with and learn from their colleagues. The case presentations are designed to provide learners with tangible examples that they might face in their own professional practice.  Further, panel discussions provide a forum for discussing key components of orthopedic densitometry.

This activity was developed with the support of an educational donation provided by Amgen.

Target Audience

The ISCD Orthopedic Osteoporosis and Densitometry Course is designed for healthcare professionals with an interest in orthopedics, osteoporosis, and bone health specifically over the age of 50, including those working in orthopedics, radiology and diagnostic imaging, physical and occupational therapy, public health, and research. These include orthopedic surgeons, physicians, nurses, nurse practitioners, physician assistants, radiology technologists, physical therapists, and occupational therapists. 

Osteoporosis, both primary and secondary, is a common problem leading to fragility fractures and poor outcomes of elective orthopedic surgery. Although orthopedic surgeons care for the majority of patients having fractures, there is a need to support training in current methods of bone health assessment, including bone densitometry. The under-diagnosis and treatment of osteoporosis continues to occur even though effective therapy exists to improve bone health and to reduce fracture risk. This gap in osteoporosis diagnosis and treatment contributes to the epidemic of new fractures and complications related to poor bone health in elective orthopedic surgery. Those caring for orthopedic patients must be familiar with and aware of current guidelines regarding osteoporosis diagnosis, fracture risk assessment, and a basic understanding of therapeutic agents.

In addition to fracture prevention and post fracture care, elective orthopedic surgery patients over age of 50 years have a significant risk of having poor bone health including osteoporosis.  Poor bone health has been associated with many adverse events of elective orthopedic surgery including periprosthetic fracture, implant subsidence, non-union and delayed union, hardware loosening, revision surgery, and overall poorer patient reported outcomes. In spine surgery, similar adverse events can occur including proximal junction failure at the end of fusions, proximal fracture with neurologic injury, and revision surgery. Unfortunately, less than 5% of orthopedic surgeons order testing for bone health prior to elective surgery.

To close the diagnosis gap, this course will review osteoporosis diagnosis guidelines, diagnostic testing basics including the application and interpretation of bone densitometry, and newer methods to assess bone health of fracture and elective surgery patients. Further, the course addresses how to initiate treatment based on clinical assessment and published guidelines. The dissemination of evidence-based information on risk/benefit balance could help reduce the treatment gap and improve patient health. Orthopedic surgeons and other members of the healthcare team may be unfamiliar with how elevated fracture risk and prevalent fragility fracture warrants pharmacological intervention of osteoporosis.

Lastly, osteoporosis is widely recognized as an important public health problem because of the related morbidity, mortality and high cost associated with fracture. Bone mineral density (BMD) measurement by dual-energy x-ray absorptiometry (DXA) is an internationally accepted standard-of-care screening and osteoporosis diagnostic tool. This course provides essential information regarding BMD acquisition, interpretation and monitoring.

Learning Objectives

After attending the course, participants should be better prepared to:

1. Describe the principles of DXA including indications, interpretation, monitoring and potential pitfalls.
2. Utilize advanced densitometry techniques such as trabecular bone score, vertebral fracture assessment, and opportunistic CT in clinical practice.
3. Ensure all fragility fracture patients receive secondary fracture care.
4. Screen elective surgery patients over age 50 years for poor bone health and provide access to osteoporosis care if warranted.
5. Understand various pharmacological treatments available and treatment algorithms.
6. Understanding the importance of sarcopenia, frailty, fall risk assessment and fall prevention.

Method of Participation

This activity will be offered in person in Boston, allowing the learner to watch and ask questions in a live format on February 22, 2025. Learners will be asked to complete a post-course survey to indicate what they will change in their practice as a result of this activity.

Rates

Cancellation Policy

Attendee Cancellation Policy All changes in registration must be made in writing to education@iscd.org. Cancellations received 30 days prior to the start of the program are eligible for a full refund minus a $50 administrative fee. Cancellations received less than 30 days prior to the start of the course will not be refunded.

Course Changes or Cancellations ISCD reserves the right to cancel the program, change dates and/or meeting location. If a program is canceled, all program fees will be refunded automatically unless the registered participant elects to transfer to another program. Participants will be notified of any changes within 21 days of the course start date.

ACCME Joint Accreditation Statement

In support of improving patient care, this activity has been planned and implemented by Amedco LLC and ISCD. Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

AMA PRA Category 1 Credit(s)™

This activity is currently under review for accreditation targeting 3.75 AMA PRA Category 1 Credit(s)^TM.

Deadline to Claim Credit

Participants will have 90 days from the activity end date to complete the activity survey and claim continuing education credit.

 Schedule - February 22, 2025 1pm - 5pm - All times Eastern Standard Time (NYC/USA)

Detailed Scheduled coming soon

Statement of Independence

The ISCD maintains a policy on the use of commercial support, which ensures that all educational activities sponsored by the ISCD provide in-depth presentations that are fair, balanced, independent, and scientifically rigorous. ISCD requires faculty, planners, managers, and other individuals and their spouse/life partner who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by ISCD for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations. Individual disclosures are included in the course material. No Commercial Support has been provided for this activity

Disclaimer

The information and suggestions presented at the courses, seminars and other programs sponsored by ISCD and other collaborating societies are subject to change and therefore should serve only as a foundation for further investigation and study. Any forms presented at our seminars or programs are samples only and are not necessarily authoritative. All information, procedures, and forms contained or used in such seminars or programs should serve only as a guide for use in specific situations.

Disclosure of Unlabeled Use

This educational activity may contain a discussion of published and/or investigational uses of agents that are not indicated by the FDA. ISCD does not recommend the use of any agent outside of the labeled indications. The opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for a discussion of approved indications, contraindications, and warnings.

Privacy & Confidentiality Statement

The ISCD will record the learner’s personal information as provided on evaluations to allow for the issuance and tracking of CME/CE certificates. The ISCD may also track aggregate responses to questions in activities and evaluations and use these data to inform the ongoing evaluation and improvement of its educational program. No individual performance data or any other personal information collected for evaluations will be shared with third parties

Attendance Cancellation Policy

All changes in registration must be made in writing to education@iscd.org. Cancellations received 30 days prior to the start of the program are eligible for a full refund minus a $50 administrative fee. Cancellations received less than 30 days prior to the start of the course will not be refunded.

Course Changes or Cancellations

ISCD reserves the right to cancel the program, change dates, how the course is taught, and/or meeting location. If a program is canceled, all program fees will be refunded unless the registered participant elects to transfer to another program. Participants will be notified of any changes within 21 days of the course start date.

Course Date

February 22, 2025.

Course Description

The Pediatric Bone Densitometry Course provides current research and best-practice techniques for the acquisition and interpretation of bone mineral density (BMD) in children and adolescents. This educational program is designed to improve learner competence in pediatric bone densitometry. By completing this course, attendees will gain conceptual and practical knowledge which can be applied in their professional practices.

Target Audience

The content is designed for healthcare providers with an interest in skeletal health assessment, including specialists, generalists and technologists working in family medicine, general and internal medicine, endocrinology, rheumatology, obstetrics/gynecology, radiology, pediatrics, physical and occupational therapy, nuclear medicine and research.

Learning Objectives

After attending the course, participants should be better prepared to:

1. Recognize considerations and concerns with skeletal assessment in children and adolescents with a variety of medical conditions.

2. Identify the most appropriate and reproducible sites for densitometry in children and adolescents.

3. Evaluate technical aspects of bone assessment in children and adolescents.

4. Describe the uses of measurement tools for acquiring bone densitometry assessments by DXA and other modalities.

5. Summarize the elements to be included in a pediatric DXA report.

Method of Participation

This activity will be offered in person in Boston, allowing the learner to watch and ask questions in a live format on February 22, 2025. Learners will be asked to complete a post-course survey to indicate what they will change in their practice as a result of this activity.

Rates

Cancellation Policy

Attendee Cancellation Policy All changes in registration must be made in writing to education@iscd.org. Cancellations received 30 days prior to the start of the program are eligible for a full refund minus a $50 administrative fee. Cancellations received less than 30 days prior to the start of the course will not be refunded.

Course Changes or Cancellations ISCD reserves the right to cancel the program, change dates and/or meeting location. If a program is canceled, all program fees will be refunded automatically unless the registered participant elects to transfer to another program. Participants will be notified of any changes within 21 days of the course start date.

ACCME Joint Accreditation Statement

In support of improving patient care, this activity has been planned and implemented by Amedco LLC and ISCD. Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

AMA PRA Category 1 Credit(s)™

This activity is currently under review for accreditation targeting 3.75 AMA PRA Category 1 Credit(s)^TM.

ASRT Credit Designation: 

This activity has been approved by ASRT for 4.5 Category A continuing education credits.

Deadline to Claim Credit

Participants will have 90 days from the activity end date to complete the activity survey and claim continuing education credit.

 Schedule - February 22, 2025 1pm - 5pm - All times Eastern Standard Time (NYC/USA)

Detailed Scheduled coming soon

Statement of Independence

The ISCD maintains a policy on the use of commercial support, which ensures that all educational activities sponsored by the ISCD provide in-depth presentations that are fair, balanced, independent, and scientifically rigorous. ISCD requires faculty, planners, managers, and other individuals and their spouse/life partner who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by ISCD for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations. Individual disclosures are included in the course material. No Commercial Support has been provided for this activity

Disclaimer

The information and suggestions presented at the courses, seminars and other programs sponsored by ISCD and other collaborating societies are subject to change and therefore should serve only as a foundation for further investigation and study. Any forms presented at our seminars or programs are samples only and are not necessarily authoritative. All information, procedures, and forms contained or used in such seminars or programs should serve only as a guide for use in specific situations.

Disclosure of Unlabeled Use

This educational activity may contain a discussion of published and/or investigational uses of agents that are not indicated by the FDA. ISCD does not recommend the use of any agent outside of the labeled indications. The opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for a discussion of approved indications, contraindications, and warnings.

Privacy & Confidentiality Statement

The ISCD will record the learner’s personal information as provided on evaluations to allow for the issuance and tracking of CME/CE certificates. The ISCD may also track aggregate responses to questions in activities and evaluations and use these data to inform the ongoing evaluation and improvement of its educational program. No individual performance data or any other personal information collected for evaluations will be shared with third parties

Attendance Cancellation Policy

All changes in registration must be made in writing to education@iscd.org. Cancellations received 30 days prior to the start of the program are eligible for a full refund minus a $50 administrative fee. Cancellations received less than 30 days prior to the start of the course will not be refunded.

Course Changes or Cancellations

ISCD reserves the right to cancel the program, change dates, how the course is taught, and/or meeting location. If a program is canceled, all program fees will be refunded unless the registered participant elects to transfer to another program. Participants will be notified of any changes within 21 days of the course start date.

Course Date

February 22, 2025.

Course Description

This course focuses on increasing the knowledge and competence of clinicians and other healthcare professionals to help them successfully use DXA body composition analysis in the management of obesity, geriatric sarcopenia and other low muscle mass states, general health and pediatric skeletal disease. The inclusion of case studies will reinforce the knowledge gained and allow for application in the diagnosis, treatment and therapies of patients presenting with low bone mineral density.

Target Audience

The content is designed for healthcare providers responsible for reading and interpreting DXA scans, including specialists and generalists working in family medicine, general and internal medicine, rheumatology, endocrinology, obstetrics/gynecology, radiology, physical and occupational therapy, and research, as well as technologists.

Learning Objectives

After attending the course, participants should be better prepared to:

• Identify proper DXA technology for body composition analysis of fat, lean muscle and bone mass.
• List other methods of body composition analysis used in the clinical setting.
• Differentiate reference values and indices.
• Identify limitations of reference values and indices.
• Summarize scan acquisition for adult and pediatric patients.

Method of Participation

This activity will be offered in person in Boston, allowing the learner to watch and ask questions in a live format on February 22, 2025. Learners will be asked to complete a post-course survey to indicate what they will change in their practice as a result of this activity.

Rates

Cancellation Policy

Attendee Cancellation Policy All changes in registration must be made in writing to education@iscd.org. Cancellations received 30 days prior to the start of the program are eligible for a full refund minus a $50 administrative fee. Cancellations received less than 30 days prior to the start of the course will not be refunded.

Course Changes or Cancellations ISCD reserves the right to cancel the program, change dates and/or meeting location. If a program is canceled, all program fees will be refunded automatically unless the registered participant elects to transfer to another program. Participants will be notified of any changes within 21 days of the course start date.

ACCME Joint Accreditation Statement

In support of improving patient care, this activity has been planned and implemented by Amedco LLC and ISCD. Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

AMA PRA Category 1 Credit(s)™

This activity is currently under review for accreditation targeting 3.75 AMA PRA Category 1 Credit(s)^TM.

ASRT Credit Designation: 

This activity has been approved by ASRT for 4.5 Category A continuing education credits.

Deadline to Claim Credit

Participants will have 90 days from the activity end date to complete the activity survey and claim continuing education credit.

 Schedule - February 22, 2025 1pm - 5pm - All times Eastern Standard Time (NYC/USA)

Detailed Scheduled coming soon

Statement of Independence

The ISCD maintains a policy on the use of commercial support, which ensures that all educational activities sponsored by the ISCD provide in-depth presentations that are fair, balanced, independent, and scientifically rigorous. ISCD requires faculty, planners, managers, and other individuals and their spouse/life partner who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by ISCD for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations. Individual disclosures are included in the course material. No Commercial Support has been provided for this activity

Disclaimer

The information and suggestions presented at the courses, seminars and other programs sponsored by ISCD and other collaborating societies are subject to change and therefore should serve only as a foundation for further investigation and study. Any forms presented at our seminars or programs are samples only and are not necessarily authoritative. All information, procedures, and forms contained or used in such seminars or programs should serve only as a guide for use in specific situations.

Disclosure of Unlabeled Use

This educational activity may contain a discussion of published and/or investigational uses of agents that are not indicated by the FDA. ISCD does not recommend the use of any agent outside of the labeled indications. The opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for a discussion of approved indications, contraindications, and warnings.

Privacy & Confidentiality Statement

The ISCD will record the learner’s personal information as provided on evaluations to allow for the issuance and tracking of CME/CE certificates. The ISCD may also track aggregate responses to questions in activities and evaluations and use these data to inform the ongoing evaluation and improvement of its educational program. No individual performance data or any other personal information collected for evaluations will be shared with third parties

Attendance Cancellation Policy

All changes in registration must be made in writing to education@iscd.org. Cancellations received 30 days prior to the start of the program are eligible for a full refund minus a $50 administrative fee. Cancellations received less than 30 days prior to the start of the course will not be refunded.

Course Changes or Cancellations

ISCD reserves the right to cancel the program, change dates, how the course is taught, and/or meeting location. If a program is canceled, all program fees will be refunded unless the registered participant elects to transfer to another program. Participants will be notified of any changes within 21 days of the course start date.

Course Date

February 19, 2025.

Course Description

This advanced densitometry course focuses on how vertebral fracture imaging advances the diagnosis and treatment of patients at risk of osteoporotic fractures. It emphasizes the importance of vertebral fractures in the clinical management of osteoporosis, including recognition of lateral spine images of a normal spine, vertebral fractures, and other findings that may be confused with vertebral fractures.  Fracture recognition, analysis, and best-practice patient positioning are detailed to ensure ideal image acquisition, interpretation, and reporting. It is recommended, but not required, that registrants attend the Osteoporosis Essentials/Quality Bone Densitometry Course (Clinician or Technologist) prior to attending the VFR course.

Target Audience

The content is designed for healthcare providers responsible for reading and interpreting DXA scans, including specialists and generalists working in family medicine, general and internal medicine, rheumatology, endocrinology, obstetrics/gynecology, radiology, nuclear medicine, physical and occupational therapy, and research. The course is also appropriate for technologists.

Learning Objectives

After attending the course, participants should be better prepared to:

1. Summarize best-practice methods utilized to recognize vertebral fractures on lateral spine images.
2. Describe non-fracture abnormalities that may appear on a spine image.
3. Identify characteristics of high-quality densitometric lateral spine images.
4. Identify the appropriate complementary technologies to complete vertebral fracture assessment.
5. Cite indications for VFA as stated in the 2015 ISCD Official Positions.

Method of Participation

This activity will be offered in person in Boston, allowing the learner to watch and ask questions in a live format on February 19, 2025. Learners will be asked to complete a post-course survey to indicate what they will change in their practice as a result of this activity.

Rates

Cancellation Policy

Attendee Cancellation Policy All changes in registration must be made in writing to education@iscd.org. Cancellations received 30 days prior to the start of the program are eligible for a full refund minus a $50 administrative fee. Cancellations received less than 30 days prior to the start of the course will not be refunded.

Course Changes or Cancellations ISCD reserves the right to cancel the program, change dates and/or meeting location. If a program is canceled, all program fees will be refunded automatically unless the registered participant elects to transfer to another program. Participants will be notified of any changes within 21 days of the course start date.

ACCME Joint Accreditation Statement:

In support of improving patient care, this activity has been planned and implemented by Amedco LLC and ISCD. Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

AMA PRA Category 1 Credit(s)™

This live activity is currently under review for accreditation targeting a maximum of 3.75 AMA PRA Category 1 Credit(s)^TM.

Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

ASRT Credit Designation 

This activity has been approved by ASRT for 4.5 Category A continuing education credits.

Deadline to Claim Credit

Participants will have 90 days from the activity end date to complete the activity survey and claim continuing education credit.

Schedule - February 19th, 2025 2:00PM - 6:00 PM - All times Eastern Standard Time (NYC/USA)

Detailed Scheduled coming soon

Statement of Independence

The ISCD maintains a policy on the use of commercial support, which ensures that all educational activities sponsored by the ISCD provide in-depth presentations that are fair, balanced, independent, and scientifically rigorous. ISCD requires faculty, planners, managers, and other individuals and their spouse/life partner who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by ISCD for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations. Individual disclosures are included in the course material. No Commercial Support has been provided for this activity

Disclaimer

The information and suggestions presented at the courses, seminars and other programs sponsored by ISCD and other collaborating societies are subject to change and therefore should serve only as a foundation for further investigation and study. Any forms presented at our seminars or programs are samples only and are not necessarily authoritative. All information, procedures, and forms contained or used in such seminars or programs should serve only as a guide for use in specific situations.

Disclosure of Unlabeled Use

This educational activity may contain a discussion of published and/or investigational uses of agents that are not indicated by the FDA. ISCD does not recommend the use of any agent outside of the labeled indications. The opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for a discussion of approved indications, contraindications, and warnings.

Privacy & Confidentiality Statement

The ISCD will record the learner’s personal information as provided on evaluations to allow for the issuance and tracking of CME/CE certificates. The ISCD may also track aggregate responses to questions in activities and evaluations and use these data to inform the ongoing evaluation and improvement of its educational program. No individual performance data or any other personal information collected for evaluations will be shared with third parties

Attendance Cancellation Policy

All changes in registration must be made in writing to education@iscd.org. Cancellations received 30 days prior to the start of the program are eligible for a full refund minus a $50 administrative fee. Cancellations received less than 30 days prior to the start of the course will not be refunded.

Course Changes or Cancellations

ISCD reserves the right to cancel the program, change dates, how the course is taught, and/or meeting location. If a program is canceled, all program fees will be refunded unless the registered participant elects to transfer to another program. Participants will be notified of any changes within 21 days of the course start date.

Course Date

February 18 & 19, 2025.

Course Description

The core elements of this program focus on performing quality DXA scans, dissecting the data and applying this knowledge to a technologist’s role in patient care. This course, which focuses on quality DXA, is innovative, interactive and informative.  The course emphasizes technical excellence in the performance, analysis and troubleshooting of bone densitometry scans. It provides standard practices and applications to raise the quality of DXA scan procedures and their impact on patient care. The program is designed to enhance awareness of the technical expertise involved in performing bone densitometry and applying protocols to address the everyday challenges. Attendees with come away with a strong sense of the considerable impact that a technologist plays in the delivery of quality DXA, and how that influences patient management.

Target Audience

The course is most appropriate for those involved in the performance of DXA scans and open to any health professional performing these scans.

Learning Objectives

After attending the course, participants should be better prepared to:

1. Design and implement quality control and assurance practices.
2. Perform a precision assessment and appreciate the requirement for clinical care.  
3. Identify the anatomy relevant to clinical DXA scanning. 
4. Implement consistent and appropriate technical acquisition and analysis techniques.  
5. Perform a fracture risk assessment using FRAX. 
6. Provide DXA interpreters sufficient information for a high-quality DXA report. 
7. Discuss supplemental software and their application.
8. Demonstrate how to access features within the DXA software. 
9. Understand how specific medical conditions and medications affect bone density. 
10. Critically evaluate DXA scans to identify acquisition and analysis errors and implement resolution methods.
11. Recognize how technical errors impact clinical interpretation and patient care.

Method of Participation

This activity will be offered in person in Boston, allowing the learner to watch and ask questions in a live format on February 18 & 19, 2025. Learners will be asked to complete a post-course survey to indicate what they will change in their practice as a result of this activity.

Rates

Cancellation Policy

Attendee Cancellation Policy All changes in registration must be made in writing to education@iscd.org. Cancellations received 30 days prior to the start of the program are eligible for a full refund minus a $50 administrative fee. Cancellations received less than 30 days prior to the start of the course will not be refunded.

Course Changes or Cancellations ISCD reserves the right to cancel the program, change dates and/or meeting location. If a program is canceled, all program fees will be refunded automatically unless the registered participant elects to transfer to another program. Participants will be notified of any changes within 21 days of the course start date.

ASRT Credit Designation 

This activity has been approved by ASRT for 13.0 Category A continuing education credits.

ASRT Credit Notice

This course is a renewal. If you have taken the course since June 2022, you will not be able to claim ASRT again for this learning activity. If you have taken prior to June 2022, you can take this course again for credit.

Deadline to Claim Credit

Participants will have 90 days from the activity end date to complete the activity survey and claim continuing education credit.

 Schedule - February 18, 2025 11am - 7pm - All times Eastern Standard Time (NYC/USA)

Detailed Scheduled coming soon

 Schedule - February 19th, 2025 8:15AM - 1:00 PM - All times Eastern Standard Time (NYC/USA)

Detailed Scheduled coming soon

Statement of Independence

The ISCD maintains a policy on the use of commercial support, which ensures that all educational activities sponsored by the ISCD provide in-depth presentations that are fair, balanced, independent, and scientifically rigorous. ISCD requires faculty, planners, managers, and other individuals and their spouse/life partner who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by ISCD for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations. Individual disclosures are included in the course material. No Commercial Support has been provided for this activity

Disclaimer

The information and suggestions presented at the courses, seminars and other programs sponsored by ISCD and other collaborating societies are subject to change and therefore should serve only as a foundation for further investigation and study. Any forms presented at our seminars or programs are samples only and are not necessarily authoritative. All information, procedures, and forms contained or used in such seminars or programs should serve only as a guide for use in specific situations.

Disclosure of Unlabeled Use

This educational activity may contain a discussion of published and/or investigational uses of agents that are not indicated by the FDA. ISCD does not recommend the use of any agent outside of the labeled indications. The opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for a discussion of approved indications, contraindications, and warnings.

Privacy & Confidentiality Statement

The ISCD will record the learner’s personal information as provided on evaluations to allow for the issuance and tracking of CME/CE certificates. The ISCD may also track aggregate responses to questions in activities and evaluations and use these data to inform the ongoing evaluation and improvement of its educational program. No individual performance data or any other personal information collected for evaluations will be shared with third parties

Attendance Cancellation Policy

All changes in registration must be made in writing to education@iscd.org. Cancellations received 30 days prior to the start of the program are eligible for a full refund minus a $50 administrative fee. Cancellations received less than 30 days prior to the start of the course will not be refunded.

Course Changes or Cancellations

ISCD reserves the right to cancel the program, change dates, how the course is taught, and/or meeting location. If a program is canceled, all program fees will be refunded unless the registered participant elects to transfer to another program. Participants will be notified of any changes within 21 days of the course start date.

Course Date

February 18 & 19, 2025.

Course Description

The core elements of this course serve to educate healthcare providers about bone densitometry and osteoporosis and to apply standard practices to assure quality performance and interpretation of bone densitometry studies. The course is offered in two parts. The first day sets the standard to perform Quality DXA interpretation. Day 2 focuses on the clinical assessment, prevention, treatment and management of osteoporosis and the essential role that high-quality DXA plays in treatment initiation decisions and monitoring of osteoporotic patients.

Target Audience

The course is most appropriate for those involved in the performance and interpretation of DXA scans and those managing patients with osteoporosis. It is open to MDs, PhDs, DOs, Nurse Practitioners, and Physician Assistants. Technologists may attend if they have previously taken the ISCD/IOF Osteoporosis Essentials for Technologists Course.

Learning Objectives

After attending the course, participants should be better prepared to:

• Describe appropriate clinical evaluation of patients at risk for fragility fracture.
• Summarize the value and importance of quality bone densitometry for the diagnosis of osteoporosis, assessment of fracture risk, and monitoring of BMD. 
• Recognize errors in DXA analysis and reporting. 
• Explain new and emerging guidelines that provide evidence-based information regarding skeletal health. 
• Describe the use of current and new pharmacologic therapies for the management and treatment of osteoporosis, including adverse effects.

Method of Participation

This activity will be offered in person in Boston, allowing the learner to watch and ask questions in a live format on February 18 & 19, 2025. Learners will be asked to complete a post-course survey to indicate what they will change in their practice as a result of this activity.

Rates

Cancellation Policy

Attendee Cancellation Policy All changes in registration must be made in writing to education@iscd.org. Cancellations received 30 days prior to the start of the program are eligible for a full refund minus a $50 administrative fee. Cancellations received less than 30 days prior to the start of the course will not be refunded.

Course Changes or Cancellations ISCD reserves the right to cancel the program, change dates and/or meeting location. If a program is canceled, all program fees will be refunded automatically unless the registered participant elects to transfer to another program. Participants will be notified of any changes within 21 days of the course start date.

ACCME Joint Accreditation Statement:

In support of improving patient care, this activity has been planned and implemented by Amedco LLC and ISCD. Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

AMA PRA Category 1 Credit(s)™

This activity is under review for accreditation targeting a maximum of 13.00 AMA PRA Category 1 Credits^TM. 

Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Deadline to Claim Credit:

Participants will have 90 days from the activity end date to complete the activity survey and claim continuing education credit.

 Schedule - February 18, 2025 11am - 7pm - All times Eastern Standard Time (NYC/USA)

Detailed Scheduled coming soon

 Schedule - February 19th, 2025 7:30AM - 1:30 PM - All times Eastern Standard Time (NYC/USA)

Detailed Scheduled coming soon

Statement of Independence

The ISCD maintains a policy on the use of commercial support, which ensures that all educational activities sponsored by the ISCD provide in-depth presentations that are fair, balanced, independent, and scientifically rigorous. ISCD requires faculty, planners, managers, and other individuals and their spouse/life partner who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by ISCD for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations. Individual disclosures are included in the course material. No Commercial Support has been provided for this activity

Disclaimer

The information and suggestions presented at the courses, seminars and other programs sponsored by ISCD and other collaborating societies are subject to change and therefore should serve only as a foundation for further investigation and study. Any forms presented at our seminars or programs are samples only and are not necessarily authoritative. All information, procedures, and forms contained or used in such seminars or programs should serve only as a guide for use in specific situations.

Disclosure of Unlabeled Use

This educational activity may contain a discussion of published and/or investigational uses of agents that are not indicated by the FDA. ISCD does not recommend the use of any agent outside of the labeled indications. The opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for a discussion of approved indications, contraindications, and warnings.

Privacy & Confidentiality Statement

The ISCD will record the learner’s personal information as provided on evaluations to allow for the issuance and tracking of CME/CE certificates. The ISCD may also track aggregate responses to questions in activities and evaluations and use these data to inform the ongoing evaluation and improvement of its educational program. No individual performance data or any other personal information collected for evaluations will be shared with third parties

Attendance Cancellation Policy

All changes in registration must be made in writing to education@iscd.org. Cancellations received 30 days prior to the start of the program are eligible for a full refund minus a $50 administrative fee. Cancellations received less than 30 days prior to the start of the course will not be refunded.

Course Changes or Cancellations

ISCD reserves the right to cancel the program, change dates, how the course is taught, and/or meeting location. If a program is canceled, all program fees will be refunded unless the registered participant elects to transfer to another program. Participants will be notified of any changes within 21 days of the course start date.

Course Date

December 7 & 8, 2024.

Course Description

The core elements of this program focus on performing quality DXA scans, dissecting the data and applying this knowledge to a technologist’s role in patient care. This course, which focuses on quality DXA, is innovative, interactive and informative.  The course emphasizes technical excellence in the performance, analysis and troubleshooting of bone densitometry scans. It provides standard practices and applications to raise the quality of DXA scan procedures and their impact on patient care. The program is designed to enhance awareness of the technical expertise involved in performing bone densitometry and applying protocols to address the everyday challenges. Attendees with come away with a strong sense of the considerable impact that a technologist plays in the delivery of quality DXA, and how that influences patient management.

Target Audience

The course is most appropriate for those involved in the performance of DXA scans and open to any health professional performing these scans.

Learning Objectives

After attending the course, participants should be better prepared to:

1. Design and implement quality control and assurance practices.
2. Perform a precision assessment and appreciate the requirement for clinical care.  
3. Identify the anatomy relevant to clinical DXA scanning. 
4. Implement consistent and appropriate technical acquisition and analysis techniques.  
5. Perform a fracture risk assessment using FRAX. 
6. Provide DXA interpreters sufficient information for a high-quality DXA report. 
7. Discuss supplemental software and their application.
   
8. Demonstrate how to access features within the DXA software. 
9. Understand how specific medical conditions and medications affect bone density. 
10. Critically evaluate DXA scans to identify acquisition and analysis errors and implement resolution methods.
11. Recognize how technical errors impact clinical interpretation and patient care.

Method of Participation

This activity will be offered through zoom, allowing the learner to watch and ask questions in a live format on December 7 & 8, 2024. Learners will be asked to complete a post-course survey to indicate what they will change in their practice as a result of this activity.

Registration Fee

Cancellation Policy

Attendee Cancellation Policy All changes in registration must be made in writing to education@iscd.org. Cancellations received 30 days prior to the start of the program are eligible for a full refund minus a $50 administrative fee. Cancellations received less than 30 days prior to the start of the course will not be refunded.

Course Changes or Cancellations ISCD reserves the right to cancel the program, change dates and/or meeting location. If a program is canceled, all program fees will be refunded automatically unless the registered participant elects to transfer to another program. Participants will be notified of any changes within 21 days of the course start date.

ASRT Credit Designation 

This activity has been approved by ASRT for 13.0 Category A continuing education credits.

ASRT Credit Notice

This course is a renewal. If you have taken the course since June 2022, you will not be able to claim ASRT again for this learning activity. If you have taken prior to June 2022, you can take this course again for credit.

Deadline to Claim Credit

Participants will have 90 days from the activity end date to complete the activity survey and claim continuing education credit.

Schedule - Day 1 - All times Eastern (NYC/USA)

Schedule - Day 2 - All times Eastern (NYC/USA)

Statement of Independence

The ISCD maintains a policy on the use of commercial support, which ensures that all educational activities sponsored by the ISCD provide in-depth presentations that are fair, balanced, independent, and scientifically rigorous. ISCD requires faculty, planners, managers, and other individuals and their spouse/life partner who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by ISCD for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations. Individual disclosures are included in the course material. No Commercial Support has been provided for this activity

Disclaimer

The information and suggestions presented at the courses, seminars and other programs sponsored by ISCD and other collaborating societies are subject to change and therefore should serve only as a foundation for further investigation and study. Any forms presented at our seminars or programs are samples only and are not necessarily authoritative. All information, procedures, and forms contained or used in such seminars or programs should serve only as a guide for use in specific situations.

Disclosure of Unlabeled Use

This educational activity may contain a discussion of published and/or investigational uses of agents that are not indicated by the FDA. ISCD does not recommend the use of any agent outside of the labeled indications. The opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for a discussion of approved indications, contraindications, and warnings.

Privacy & Confidentiality Statement

The ISCD will record the learner’s personal information as provided on evaluations to allow for the issuance and tracking of CME/CE certificates. The ISCD may also track aggregate responses to questions in activities and evaluations and use these data to inform the ongoing evaluation and improvement of its educational program. No individual performance data or any other personal information collected for evaluations will be shared with third parties

Attendance Cancellation Policy

All changes in registration must be made in writing to education@iscd.org. Cancellations received 30 days prior to the start of the program are eligible for a full refund minus a $50 administrative fee. Cancellations received less than 30 days prior to the start of the course will not be refunded.

Course Changes or Cancellations

ISCD reserves the right to cancel the program, change dates, how the course is taught, and/or meeting location. If a program is canceled, all program fees will be refunded unless the registered participant elects to transfer to another program. Participants will be notified of any changes within 21 days of the course start date.

Course Date

December 7 & 8, 2024.

Course Description

The core elements of this course serve to educate healthcare providers about bone densitometry and osteoporosis and to apply standard practices to assure quality performance and interpretation of bone densitometry studies. The course is offered in two parts. The first day sets the standard to perform Quality DXA interpretation. Day 2 focuses on the clinical assessment, prevention, treatment and management of osteoporosis and the essential role that high-quality DXA plays in treatment initiation decisions and monitoring of osteoporotic patients. Individuals may register for either part of the course separately or as a combined program.

Target Audience

The course is most appropriate for those involved in the performance and interpretation of DXA scans and those managing patients with osteoporosis. It is open to MDs, PhDs, DOs, Nurse Practitioners, and Physician Assistants. Technologists may attend if they have previously taken the ISCD/IOF Osteoporosis Essentials for Technologists Course.

Learning Objectives

After attending the course, participants should be better prepared to:

• Describe appropriate clinical evaluation of patients at risk for fragility fracture.
• Summarize the value and importance of quality bone densitometry for the diagnosis of osteoporosis, assessment of fracture risk, and monitoring of BMD. 
• Recognize errors in DXA analysis and reporting. 
• Explain new and emerging guidelines that provide evidence-based information regarding skeletal health. 
• Describe the use of current and new pharmacologic therapies for the management and treatment of osteoporosis, including adverse effects.

Method of Participation

This activity will be offered live streamed via Zoom, allowing the learner to watch and ask questions in a live format on December 7 & 8, 2024. Learners will be asked to complete a post-course survey to indicate what they will change in their practice as a result of this activity.

Rates

Cancellation Policy

Attendee Cancellation Policy All changes in registration must be made in writing to education@iscd.org. Cancellations received 30 days prior to the start of the program are eligible for a full refund minus a $50 administrative fee. Cancellations received less than 30 days prior to the start of the course will not be refunded.

Course Changes or Cancellations ISCD reserves the right to cancel the program, change dates and/or meeting location. If a program is canceled, all program fees will be refunded automatically unless the registered participant elects to transfer to another program. Participants will be notified of any changes within 21 days of the course start date.

ACCME Joint Accreditation Statement:

In support of improving patient care, this activity has been planned and implemented by Amedco LLC and ISCD. Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

AMA PRA Category 1 Credit(s)™

This activity is under review for accreditation targeting a maximum of 13.00 AMA PRA Category 1 Credits^TM. 

Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Deadline to Claim Credit:

Participants will have 90 days from the activity end date to complete the activity survey and claim continuing education credit.

 Schedule - December 7th, 2024 - All times Eastern Standard Time (NYC/USA)

 Schedule - December 8th, 2024 - All times Eastern Standard Time (NYC/USA)

Statement of Independence

The ISCD maintains a policy on the use of commercial support, which ensures that all educational activities sponsored by the ISCD provide in-depth presentations that are fair, balanced, independent, and scientifically rigorous. ISCD requires faculty, planners, managers, and other individuals and their spouse/life partner who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by ISCD for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations. Individual disclosures are included in the course material. No Commercial Support has been provided for this activity

Disclaimer

The information and suggestions presented at the courses, seminars and other programs sponsored by ISCD and other collaborating societies are subject to change and therefore should serve only as a foundation for further investigation and study. Any forms presented at our seminars or programs are samples only and are not necessarily authoritative. All information, procedures, and forms contained or used in such seminars or programs should serve only as a guide for use in specific situations.

Disclosure of Unlabeled Use

This educational activity may contain a discussion of published and/or investigational uses of agents that are not indicated by the FDA. ISCD does not recommend the use of any agent outside of the labeled indications. The opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for a discussion of approved indications, contraindications, and warnings.

Privacy & Confidentiality Statement

The ISCD will record the learner’s personal information as provided on evaluations to allow for the issuance and tracking of CME/CE certificates. The ISCD may also track aggregate responses to questions in activities and evaluations and use these data to inform the ongoing evaluation and improvement of its educational program. No individual performance data or any other personal information collected for evaluations will be shared with third parties

Attendance Cancellation Policy

All changes in registration must be made in writing to education@iscd.org. Cancellations received 30 days prior to the start of the program are eligible for a full refund minus a $50 administrative fee. Cancellations received less than 30 days prior to the start of the course will not be refunded.

Course Changes or Cancellations

ISCD reserves the right to cancel the program, change dates, how the course is taught, and/or meeting location. If a program is canceled, all program fees will be refunded unless the registered participant elects to transfer to another program. Participants will be notified of any changes within 21 days of the course start date.

Activity approved for 1.5 ASRT Category A Credits
Activity approved for up to 1.00 AMA PRA Category 1 Credits™ 
Activity Expires October 14, 2025

Activity Description

This talk will review the clinical presentation, diagnosis, and management of hypophosphatasia in a case-based format.

Learning Objectives:

1. Establish an approach to thinking about hypophosphatasia (HPP) and when you should be concerned about this disease in patients.
2. Learn the different clinical manifestations of HPP in adults.
3. Discuss diagnosis and management of HPP.

Instructions:

Clinicians and Technologists are required to answer a set of online test questions following the review of the video and will have up to three attempts to answer questions correctly before losing credit for the activity. Once the activity test has been passed (75% or higher), you will be asked to evaluate the activity online and then be allowed to claim credit and print certificates.

Registration Fees

Cancellation Policy

On-Demand/ Enduring Material Cancellation
Purchases of on-demand or enduring educational materials are non-refundable.

On-Demand/Enduring Material Program Changes or Cancellations 
ISCD reserves the right to cancel the program, change dates, and/or the location/method of offering. All program fees will be refunded if a program is canceled unless the registered participant elects to transfer to another program.

Joint Accreditation Statement:

In support of improving patient care, this activity has been planned and implemented by Amedco LLC and ISCD. Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

AMA PRA Category 1 Credit(s)™

Amedco LLC designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credits^TM for physicians. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ASRT Credit Designation 

This activity has been approved by ASRT for 1.5 Category A continuing education credits.

Date of Original Release and most recent Review or Update 

This activity was most recently reviewed and released on October 15th, 2024.

Statement of Independence

The ISCD maintains a policy on the use of commercial support, which ensures that all educational activities sponsored by the ISCD provide in-depth presentations that are fair, balanced, independent, and scientifically rigorous. ISCD requires faculty, planners, managers, and other individuals and their spouse/life partner who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by ISCD for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations. Individual disclosures are included in the course material. No Commercial Support has been provided for this activity

Disclaimer

The information and suggestions presented at the courses, seminars and other programs sponsored by ISCD and other collaborating societies are subject to change and therefore should serve only as a foundation for further investigation and study. Any forms presented at our seminars or programs are samples only and are not necessarily authoritative. All information, procedures, and forms contained or used in such seminars or programs should serve only as a guide for use in specific situations.

Disclosure of Unlabeled Use 

This educational activity may contain a discussion of published and/or investigational uses of agents that are not indicated by the FDA. ISCD does not recommend the use of any agent outside of the labeled indications. The opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Privacy & Confidentiality Statement

The ISCD will record the learner’s personal information as provided on evaluations to allow for the issuance and tracking of CME/CE certificates. The ISCD may also track aggregate responses to questions in activities and evaluations and use these data to inform the ongoing evaluation and improvement of its educational program. No individual performance data or any other personal information collected for evaluations will be shared with third parties

Attendee Cancellation Policy

All changes in registration must be made in writing to education@iscd.org. Purchase of on-demand or enduring educational materials are non-refundable.

Course Changes or Cancellations

ISCD reserves the right to cancel the program and change the dates of the offering. All program fees will be refunded if a program is canceled unless the registered participant elects to transfer to another program.

Activity approved for up to 1.00 AMA PRA Category 1 Credits™ 
Activity Expires October 14, 2025

Activity Description

Describe guidelines on screening and treating low bone mass prior to spinal fusion surgery.

Learning Objectives:

1. Review surgical indications.
2. Define Deformity and how it complicates DXA.
3. Determine the impact of preoperative pharmacotherapy on spine fusion outcomes and reducing risk for osteoporosis related complications.
4. Review current guidelines and literature on bone optimization, screening guidelines, and treatment algorithm.
5. Understand effectiveness.

Instructions:

Clinicians and Technologists are required to answer a set of online test questions following the review of the video and will have up to three attempts to answer questions correctly before losing credit for the activity. Once the activity test has been passed (75% or higher), you will be asked to evaluate the activity online and then be allowed to claim credit and print certificates.

Registration Fees

Cancellation Policy

On-Demand/ Enduring Material Cancellation
Purchases of on-demand or enduring educational materials are non-refundable.

On-Demand/Enduring Material Program Changes or Cancellations 
ISCD reserves the right to cancel the program, change dates, and/or the location/method of offering. All program fees will be refunded if a program is canceled unless the registered participant elects to transfer to another program.

Joint Accreditation Statement:

In support of improving patient care, this activity has been planned and implemented by Amedco LLC and ISCD. Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

AMA PRA Category 1 Credit(s)™

Amedco LLC designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credits^TM for physicians. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Date of Original Release and most recent Review or Update 

This activity was most recently reviewed and released on October 15th, 2024.

Statement of Independence

The ISCD maintains a policy on the use of commercial support, which ensures that all educational activities sponsored by the ISCD provide in-depth presentations that are fair, balanced, independent, and scientifically rigorous. ISCD requires faculty, planners, managers, and other individuals and their spouse/life partner who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by ISCD for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations. Individual disclosures are included in the course material. No Commercial Support has been provided for this activity

Disclaimer

The information and suggestions presented at the courses, seminars and other programs sponsored by ISCD and other collaborating societies are subject to change and therefore should serve only as a foundation for further investigation and study. Any forms presented at our seminars or programs are samples only and are not necessarily authoritative. All information, procedures, and forms contained or used in such seminars or programs should serve only as a guide for use in specific situations.

Disclosure of Unlabeled Use 

This educational activity may contain a discussion of published and/or investigational uses of agents that are not indicated by the FDA. ISCD does not recommend the use of any agent outside of the labeled indications. The opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Privacy & Confidentiality Statement

The ISCD will record the learner’s personal information as provided on evaluations to allow for the issuance and tracking of CME/CE certificates. The ISCD may also track aggregate responses to questions in activities and evaluations and use these data to inform the ongoing evaluation and improvement of its educational program. No individual performance data or any other personal information collected for evaluations will be shared with third parties

Attendee Cancellation Policy

All changes in registration must be made in writing to education@iscd.org. Purchase of on-demand or enduring educational materials are non-refundable.

Course Changes or Cancellations

ISCD reserves the right to cancel the program and change the dates of the offering. All program fees will be refunded if a program is canceled unless the registered participant elects to transfer to another program.